The QualityStocks Daily Wednesday, August 12th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (WARM) +46.86%

MarketClub Analysis (EYEG) +31.22%

Kiplinger Today (SHLDQ) +27.60%

The QualityStocks Daily Stock List

CounterPath Corporation (CPAH)

Stocklight, OTC Markets, ChartMill, Street Insider, Investors Observer, TradingView, Wallet Investor, Morningstar, MacroTrends, InvestorsHub, Finbox, Barchart, Alpha Stock News, Market Screener, Investing.com, YCharts, Zacks, Stocknews, Stockhouse, Finviz, Seeking Alpha, MarketBeat, Nasdaq, Stocktwits, MarketWatch, and Stockopedia reported previously on CounterPath Corporation (CPAH), and we also report on the Company, here at the QualityStocks Daily Newsletter.

CounterPath Corporation is a worldwide provider of award-winning Unified Communications and Collaboration (UCC) solutions for enterprises and service providers. The Company is transforming how people communicate in today's modern mobile workforce. It has its award-winning Bria® solutions for desktop and mobile devices. CounterPath's SIP-based VoIP softphones connect businesses with the world. Established in 2002, CounterPath has its corporate office in Vancouver, British Columbia. The Company lists on the NasdaqGS.

Fundamentally, CounterPath’s corporate mission is to be the provider of VoIP technology, which empowers people to connect, communicate, and collaborate using voice, video, messaging, and presence - on numerous devices, across manifold platforms and over fixed and mobile networks. The Company licenses its products to customers who subsequently deploy them to their consumer and business customer base. CounterPath receives licensing revenue on a per seat or per subscriber basis, and also development, implementation, and support revenues.

CounterPath’s award-winning Bria solutions for desktop and mobile devices enable organizations to take advantage of their existing PBX and hosted voice call servers to extend seamless and secure unified communications and collaboration services to users regardless of their location and network. CounterPath technology meets the unique requirements of a number of industries. These include the contact center, retail, warehouse, hospitality, as well as healthcare verticals. The Company’s solutions are deployed globally by 8×8, Airbnb, AmeriSave, BT, Citibank, Comcast, Fusion, Fuze, Liberty Global, Uber, Windstream, and others.

Bria softphones for desktop, tablet, and mobile devices, together with the Stretto Platform™ server solutions, enable service providers, original equipment manufacturers (OEMs) and enterprises large and small worldwide to provide a seamless and unified communications experience across any networks. The Bria and Stretto combination enables an improved user experience as an overlay to the most popular UC and IMS telephony and application servers on the market today.

Recently, CounterPath announced that its Bria Enterprise solution has enabled Genesis Financial Solutions to speedily adapt to remote working conditions in light of the COVID-19 pandemic. Genesis Financial Solutions is the foremost provider of near-prime consumer financing through general purpose and private label credit card solutions.

Mr. Todd Carothers, Chief Revenue Officer at CounterPath, said, "After years of increasing interest in a remote working approach, we're seeing an influx of organizations looking to move to that model, fast. We are in a great position to help companies like Genesis Financial Solutions seamlessly switch to this new way of working. With the help of Bria Enterprise, no matter how disperse Genesis Financial Solutions workforce may be, we can quickly turn up users no matter where they are located."

CounterPath Corporation (CPAH), closed Wednesday's trading session at $4.11, off by 0.242718%, on 8,158 volume with 76 trades. The average volume for the last 3 months is 81,296 and the stock's 52-week low/high is $0.829999983/$6.00.

chart

Harte Gold Corp. (HRTFF)

Market Screener, Metals News, GlobeNewswire, Seeking Alpha, Nasdaq, EIN Presswire, Inside Exploration, Small Cap Exclusive, NetNewsLedger, Gold Stock Data, YCharts, Junior Mining Network, Resource World, Northern Miner, Barchart, Stockwatch, InvestorsHub, Stockhouse, hot Stocked, Mine Connect, Macroaxis, Proactive Investors, Wallet Investor, Investor Intel, Morningstar, Dividend.com, and GuruFocus reported beforehand on Harte Gold Corp. (HRTFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Harte Gold Corp. engages in the acquisition and exploration of mineral resource properties in Canada. The Company has operations in White River, Ontario. It earlier permitted and put into production the Province of Ontario’s newest high-grade gold mine. The Company was previously known as Harte Resources Company. It changed its corporate name to Harte Gold Corp. in December of 2003. Incorporated in 1982, Harte Gold is headquartered in Toronto, Ontario.

Harte Gold is Ontario’s newest gold producer via its wholly-owned Sugar Zone Mine in White River Ontario. The Company holds a 100 percent interest in the property. The Sugar Zone Property is roughly 80 km east of the Hemlo gold camp and 24 km north of White River off the Trans-Canada Highway (#17).

In 2019, the Sugar Zone Mine entered commercial production. This Property covers 79,335 hectares encompassing a significant greenstone belt. Using a 3 g/t gold cut-off, the NI 43-101 compliant Mineral Resource Estimate dated February 19, 2019 contains an Indicated Mineral Resource of 4,243,000 tonnes grading 8.12 g/t Au with 1,108,000 ounces contained gold and an Inferred Mineral Resource of 2,954,000 tonnes, grading 5.88 g/t Au with 558,000 ounces contained gold.

An NI 43-101 compliant Feasibility Study (FS) was completed on the Sugar Zone Mine effective February 15, 2019. It calculated total Reserves of 3,879,000 tonnes grading 7.1 g/t Au with 890,000 ounces of gold. Exploration continues on the Sugar Zone Property.

Harte Gold also has its Stoughton-Abitibi Property. This Property is on and adjacent to the Destor-Porcupine Fault, 110 km east of Timmins, 50 km north-east of Kirkland Lake, Ontario, and 10 km due east of the Holloway-Holt gold mine and mill. The Stoughton-Abitibi Property is not a material property to Harte Gold. Nonetheless, Company Management intends to evaluate historic data associated with the Stoughton-Abitibi property so as to measure the scope of future potential exploration programs.

Last month, Harte Gold announced that it signed a binding agreement with ANR Investments 2 B.V. (Appian) providing for up to US$30 million in financing and closed a related US$9.5 million Private Placement. The Private Placement is part of the financing package to facilitate a restart of the Sugar Zone mining operation, as earlier announced on July 1, 2020.

9,500,000 Series B special shares of Harte Gold were issued through a private placement to ANR Investments B.V. (ANR) at a price of US$1.00 per Special Share for aggregate gross proceeds of US$9.5 million. Proceeds will be used to fund working capital needs, the restart of the Sugar Zone Mine, and general corporate purposes.

Harte Gold Corp. (HRTFF), closed Wednesday's trading session at $0.1434, up 4.0767%, on 35,400 volume with 16 trades. The average volume for the last 3 months is 83,685 and the stock's 52-week low/high is $0.0535/$0.258300006.

chart

Magellan Gold Corporation (MAGE)

Mining Capital, Mining Clips, Stock Analysis, Wallet Investor, Junior Mining Network, Dividend Investor, InvestorsHub, Smart Stock Trading Strategies, 4-Traders, Stockopedia, The OTC Reporter, Mining Stock Valuator, last10k, Financial Buzz, Street Insider, Equities, Proactive Investors, Market Screener, Investors Hangout, Stockwatch, Stockhouse, Mexico Mining Center, and YCharts reported beforehand on Magellan Gold Corporation (MAGE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Magellan Gold Corporation intends to establish itself as a major player in the precious metals mining field. It is an exploration stage company and its principal business is the acquisition, exploration, and if warranted, development of mineral resources. Magellan Gold controls projects consisting of the SDA Mill, Mexico; and the El Dorado Gold-Silver Project near the SDA Mill. Magellan Gold is headquartered in Albuquerque, New Mexico.

The Company’s intention is to build up production via the SDA Mill and increase cash flow. Initial production from the El Dorado Gold-Silver Project was planned for 2019, with the ore to be trucked to the SDA Mill for treatment. Other precious metals properties within trucking distance of the SDA Mill have been identified for acquisition. Furthermore, Magellan Gold will leverage opportunities to treat ore on a toll basis for third-party suppliers.

The SDA Processing Plant is a permitted, fully operational flotation mill with a gold-silver leach circuit, situated in Nayarit State, Mexico. The SDA Processing Plant (SDA Mill) is 150 kilometers southeast of the City of Mazatlan near the town of Acaponeta, Nayarit. Magellan Gold purchased the SDA Mill and associated assets, licenses, and agreements in November of 2017.

The El Dorado Gold-Silver Project is planned to be developed as an underground mine to supply feed to the SDA Mill. The El Dorado Gold-Silver Project is near the village of Las Minitas, State of Nayarit, 50 kilometers south of the SDA Processing Plant. The El Dorado Mining Concession consists of a 50-hectare concession valid until March 2030. Magellan holds the concession under an option to purchase.

The Silver District Project is an advanced-stage exploration project in southwest Arizona. In January 2020, the Company announced that it entered into a binding Letter of Intent (LOI) to sell 100 percent of its Silver District project in La Paz County, Arizona, to NV Gold Corporation (TSXV: NVX, US: NVGLF) for cash, NVX shares, and a minimum work commitment over a five-year period.

Last month, Magellan Gold announced that it acquired additional unpatented mining claims in proximity to the unpatented claims comprising the historic Center Star Gold Mine near Elk City, Idaho that was acquired effective July 1, 2020. Magellan has added an additional 320 acres of land to increase its holding to 620 acres of claims along the Center Star gold trend. The new claims are situated in proximity to the earlier acquired claims. They were staked to fortify the land position around Center Star Mine.

The Center Star Mine hosts high grade gold mineralization that was discovered in the early 1900’s, with periodic historic production and development work done under varied ownership through the 1980s. This property is 45 miles from Grangeville, Idaho and near the town of Elk City, Idaho.

Last week, Magellan Gold announced the appointment of Mr. Michael Lavigne as President and Director effective August 1, 2020. In addition to Mr. Lavigne, Mr. Gregory Schifrin was appointed as Director, following Magellan Gold’s acquisition of Clearwater Gold Mining Corporation announced last month. Mr. Lavigne has been involved in the mining industry since 1975. Mr. Schifrin has worked as a geologist and manager for more than 36 years in the mining and mineral exploration industry.

Magellan Gold Corporation (MAGE), closed Wednesday's trading session at $1.45, off by 7.6433%, on 7,916 volume with 21 trades. The average volume for the last 3 months is 5,501 and the stock's 52-week low/high is $0.200000002/$2.50.

chart

MannKind Corporation (MNKD)

Investor Village, BioPharmCatalyst, MarketBeat, AlphaStreet, ValueWalk, Investors Observer, GlobeNewswire, ChartMill, Investing.com, Barchart, YCharts, Invest Chronicle, Proactive Investors, Morningstar, Equities.com, Stockhouse, Investor Place, DBT News, ETF Channel, Business Insider, ETF.com, NewsDaemon, Nasdaq, Seeking Alpha, Finviz, TMXmoney, Stocktwits, MarketWatch, and Stocknews reported earlier on MannKind Corporation (MNKD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases. With its ultra rapid-acting inhaled insulin, Afrezza®, the Company is changing the way diabetes is treated. Additionally, with its innovative and powerful Technosphere® technology, MannKind is developing new ways for people with orphan and other serious lung diseases to take control of their health. Founded in 1991, MannKind is headquartered in Westlake Village, California. Its manufacturing facility is in Danbury, Connecticut.

At present, MannKind is commercializing Afrezza® (insulin human) Inhalation Powder. This is its first Food and Drug Administration (FDA)-approved product and the only inhaled ultra rapid-acting mealtime insulin in the USA, where it is available by prescription from pharmacies across the nation.

Afrezza utilizes the Company’s proprietary Technosphere® Technology. This is an unique, dry-powder formulation technology that enables medication to be delivered via the lungs. MannKind’s Technosphere® Technology can be applied to several therapeutic areas that are both in high demand for innovation, and in need for a different kind of treatment option for people.

This past June, MannKind announced that new data from clinical studies of Afrezza® (insulin human) Inhalation Powder was presented at the American Diabetes Association’s 80th Scientific Sessions, June 12-16, 2020. The data presented included a comprehensive post hoc analysis of four unique studies assessing the safe and effective dosing of Afrezza in patients with type 1 diabetes (Poster 1023).

Data presented also included an analysis demonstrating treatment with Afrezza is associated with weight loss in patients with type 2 diabetes, versus weight gain with injected mealtime insulin (Poster 1024). In addition, data presented included an evaluation of a comprehensive two year safety study showing that significant changes in FEV1 (as a measure of pulmonary function) during treatment with Afrezza are both uncommon and generally transient in nature (Oral Abstract 235).

Last week, MannKind reported financial results for the quarter and six months ended June 30, 2020. The Company had Q2 2020 Afrezza Net Revenue of $7.0 million; this is up 15 percent in comparison to Q2 2019. First Half (1H) 2020 Afrezza Net Revenue was $15.0 million. This is up 35 percent in comparison to 1H 2019.

MannKind reported Cash and Cash Equivalents of $63.2 million at June 30, 2020. Non-GAAP Cash Used in Operating Activities decreased by 37 percent in comparison to 1H 2019.

MannKind Corporation (MNKD), closed Wednesday's trading session at $1.63, up 1.875%, on 1,937,297 volume with 4,041 trades. The average volume for the last 3 months is 3,512,292 and the stock's 52-week low/high is $0.800000011/$2.48000001.

chart

Adriatic Metals PLC (ADMLF)

Stock Target Advisor, Investing.com, Stock News Now, MarketWatch, Market Screener, The Assay, Stockhouse, TeleTrader, TipRanks, Wallet Investor, Ceo.ca, Newsfilecorp, Dividend.com, Stockwatch, Morningstar, Seeking Alpha, GuruFocus, StocksCafe, Junior Mining Network, MarketBeat, Dividend Investor, TradingView, Proactive Investors, and OTC Markets reported previously on Adriatic Metals PLC (ADMLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Adriatic Metals PLC, via its subsidiary, Eastern Mining d.o.o Sarajevo, engages in the mineral exploration business in Bosnia and Herzegovina. The Company explores for zinc, lead, barite, barium sulfate, silver, gold, and copper deposits. Incorporated in 2017, Adriatic Metals is based in Cheltenham, the United Kingdom (UK). The Company’s shares trade on the OTC Markets.

Adriatic Metals holds a 100 percent interest in the Vareš Project positioned in the Federation of Bosnia and Herzegovina. This is an advanced polymetallic project leveraged to precious and base metal exposure. It is a high grade resource with first-rate metallurgy. It is a high margin, high return, low capex (capital expenditure) Project.

The economically viable Vareš Project consists of two high grade polymetallic deposits. These are the Rupice and Veovača deposits. Pertaining to the Rupice high grade polymetallic deposit, it has a Maiden JORC 2012 Resource of 9.4Mt – 80 percent of the Mineral Resource is in the Indicated Resources category. Mineralization remains open in all directions and highest grade intercepts to date exceed 58m at 58.9 percent ZnEq or 27.0 g/t AuEq.

Regarding the Veovača deposit, it is a Brownfield Mine with growth potential. It has an updated JORC 2012 Mineral Resource of 7.4Mt. It previously produced zinc, lead, and barite concentrate between 1983 and 1987. Drilling at Veovača has added gold and silver into the entirety of the Mineral Resource estimate. Resources start at the surface and currently extend down to depths of 200 meters.

Additionally, the Vareš Project neighbors Tier-1 deposits and has a well defined permitting process. Concerning the 2020 Exploration Programme, the Project has an increasing resource inventory and extensive data to support new concession applications.

The Vareš Project is surrounded by established infrastructure and major discoveries. It is well positioned in central Europe with wide access to rail networks linking European smelters and the seaborne market.

This past June, Adriatic Metals announced that it entered into a definitive arrangement agreement respecting the earlier announced proposed acquisition of Tethyan Resource Corp. by Adriatic Metals. With this agreement, Adriatic will acquire 100 percent of the outstanding common shares of Tethyan Resource, through a plan of arrangement under the Business Corporations Act (British Columbia), in consideration for the issuance of 0.166 of an ordinary share of Adriatic Metals for each common share of Tethyan Resource outstanding at the effective time of the Arrangement.

Upon completion of the Arrangement, Tethyan Resource will apply to delist the Tethyan Shares from the TSX Venture Exchange. Tethyan Resource is a precious and base metals mineral exploration company. It is concentrating on the Tethyan Metallogenic Belt in Eastern Europe, primarily Serbia.

Adriatic Metals PLC (ADMLF), closed Wednesday's trading session at $1.71, off by 8.0645%, on 3,069 volume with 8 trades. The average volume for the last 3 months is 26,855 and the stock's 52-week low/high is $0.50999999/$2.19000005.

chart

Discovery Metals Corp. (DSVMF)

The Prospector News, FX Empire, Stock Day Media, Stockwatch, Proactive Investors, InvestorX, GuruFocus, TradingView, Wallet Investor, Morningstar, Dividend Investor, Digital Journal, PR Newswire, Nasdaq, Simply Wall St, Vrify, OTC Markets, InvestorsHub, GlobeNewswire, MarketWatch, Stockhouse, Resource World, Barchart, and Seeking Alpha reported previously on Discovery Metals Corp. (DSVMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Discovery Metals Corp. is an exploration and development company listed on the OTC Markets Group’s OTCQX. It focuses on historic mining districts in Mexico. The Company’s flagship project is its 100 percent-owned Cordero Silver Project in Chihuahua State, Mexico. Discovery Metals has its corporate headquarters in Toronto, Ontario. The Company is part of the Oxygen Group of companies. Mr. Eric Sprott is Discovery Metals’ largest shareholder.

The 35,000-hectare Cordero Silver Project property encompasses a large district, which hosts the announced resource as well as manifold exploration targets for bulk tonnage diatreme-hosted, porphyry-style, and carbonate replacement deposits. The Cordero Silver Project is situated on the eastern edge of the Sierra Madre Occidental mountains in the northern part of the Central Mexican Silver Belt. This is Mexico’s premier porphyry and carbonate replacement deposit district.

Mineralization at the Cordero Silver Project is alike in nature to well-known nearby bulk tonnage precious metals mines and projects (e.g. Newmont Corporation’s Peñasquito Mine and Orla Mining Ltd.’s Camino Rojo project). Further to the bulk tonnage mineralization, there are also multiple high-grade silver-zinc-lead-gold sulphide vein trends as evidenced by greater than 40 historical shallow, vertical shafts and associated underground workings.

Following completion of a successful PEA (Preliminary Economic Assessment) in April of 2018, the current Indicated and Inferred resources, combined with the Project’s eight large-scale mineral targets on over 370 square kilometers, have established the Cordero Silver Project as a world-class property and a district-scale discovery ready for pre-feasibility studies.

Since acquiring Cordero in August of 2019, Discovery Metals’ emphasis has been on understanding the nature of the higher-grade zones within the larger mineralized system with the goal of upgrading the economic potential of the Project. The Company initiated a Phase 1 drill program totalling 30,000-35,000m in September of 2019. It expects to complete the full drill program through the course of this year. In conjunction with the drill program, Discovery also intends to advance property wide targets to drill ready status this year.

Discovery Metals Corp. (DSVMF), closed Wednesday's trading session at $1.82, up 7.0588%, on 914,187 volume with 992 trades. The average volume for the last 3 months is 571,291 and the stock's 52-week low/high is $0.125/$2.1400001.

chart

Evofem Biosciences, Inc. (EVFM)

BioPharmCatalyst, Stocknews, Nasdaq, Stockhouse, Stocktwits, 4-Traders, Street Insider, TipRanks, Market Screener, Simply Wall St, YCharts, DBT News, ETF Channel, Seeking Alpha, Investing.com, PR Newswire, GuruFocus, Finbox, Proactive Investors, Morningstar, Barchart, and Stockwatch reported beforehand on Evofem Biosciences, Inc. (EVFM), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company listed on the NasdaqGS. It is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. Evofem is working to advance the quality of life for women by developing unique solutions, such as hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Evofem Biosciences has its corporate headquarters in San Diego, California.

The Company's first commercial product is Phexxi™ (lactic acid, citric acid, and potassium bitartrate). It is approved in the U.S. for the prevention of pregnancy. Phexxi™ is a non-hormonal birth control indicated for the prevention of pregnancy in females of reproductive potential for use as an on‑demand method of contraception.

Evofem Biosciences is advancing EVO100 for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Drug candidate EVO100 has been granted Fast Track Designation for the prevention of chlamydia in women and Qualified Infectious Disease Product (QIDP) Designation for the prevention of gonorrhea in women by the U.S. Food and Drug Administration (FDA).

The Phase 2b AMPREVENCE study evaluating EVO100 for the prevention of chlamydia and gonorrhea met its primary and secondary endpoints. Moreover, EVO100 was generally safe and well tolerated.

Last week, Evofem Biosciences reported financial results for the three- and six- month periods ended June 30, 2020. Total Operating Expenses were $22.4 million for the quarter ended June 30, 2020, versus $11.9 million for the quarter ended June 30, 2019. Research and Development (R&D) costs for Q2 of 2020 were $2.6 million, versus $5.2 million in the previous year quarter. This reflects a $2.3 million decrease in Clinical Trial Costs because of completion of the AMPREVENCE trial in Q4 of 2019.

Net Loss Attributable to Common Stockholders was $52.7 million, or $(0.91) per share, for the quarter ended June 30, 2020, versus a Net Loss of $35.5 million, or $(0.97) per share, for the previous year quarter. Unrestricted Cash and Short-Term Investments were $123.6 million at June 30, 2020, versus $23.8 million at December 31, 2019.

Evofem Biosciences is advancing pre-commercial activities in preparation for Phexxi™ commercial launch this September. In addition, the pivotal Phase 3 Trial of EVO100 for the prevention of Chlamydia and Gonorrhea is on track for Q4 2020 initiation.

Evofem Biosciences, Inc. (EVFM), closed Wednesday's trading session at $2.95, even for the day, on 1,846,540 volume with 7,534 trades. The average volume for the last 3 months is 3,999,560 and the stock's 52-week low/high is $2.73000001/$7.50.

chart

Cool Technologies, Inc. (WARM)

Hotstocked, Street Insider, Stockhouse, Nasdaq, TipRanks, Investing.com, TeleTrader, Emerging Growth, MarketBeat, Market Screener, Wallet Investor, TradingView, Morningstar, last10k, 4-Traders, Dividend Investor, ValueForum, The Street, InvestorsHub, GlobeNewswire, and Market Exclusive reported beforehand on Cool Technologies, Inc. (WARM), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Cool Technologies, Inc. is an innovator in efficient mobile electric power generation and power enhancement technologies for motors and generators. The Company is an intellectual property (IP) and product development enterprise commercializing patented thermal dispersion technology across numerous platforms. It formerly went by the name HPEV, Inc. It changed its name to Cool Technologies, Inc. in August of 2015. Established in February 2011, Cool Technologies has its corporate headquarters in Tampa, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Cool Technologies operates in three addressable markets. These are Mobile Generation, Motors & Generators, and Pumps. Mobile Generation (MG) removes the need for tow-behind generators. A Proprietary Gearing System draws power from the truck’s engine. MG reduces size and increases the efficiency of the generator. The MG system transforms any existing or new Class 3-8 truck into a mobile generator.

Motors & Generators removes heat more efficiently and increases power density. In addition, it reduces costs by up to 25 percent. Moreover, Pumps – Water and Wastewater - removes extremely high maintenance costs. It also doubles pump output.

Concerning the Company’s IP for Thermal Technology, 7 patents cover various types of heat removal from electric motors, generators, electronics, battery packs, controls, brakes, clutches, and more. All incorporate the inventive application of heat pipes. Cool Technologies’ thermal dispersion technology transfers heat through heat pipes with innovative capabilities. The heat pipes move heat in any direction (even against gravity) and necessitate little or no maintenance. The cooler a motor runs, the greater its potential output.

Cool Technologies, Inc. (WARM), closed Wednesday's trading session at $0.02225, up 46.8647%, on 8,959,994 volume with 247 trades. The average volume for the last 3 months is 1,816,255 and the stock's 52-week low/high is $0.002899999/$0.056899998.

chart

Adynxx, Inc. (ADYX)

TipRanks, TMXmoney, Xconomy, Street Insider, Investing.com, BioCentury, Stockhouse, Market Screener, TradingView, Stockopedia, Dividend Investor, GlobeNewswire, and PR Newswire reported previously on Adynxx, Inc. (ADYX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A clinical stage biopharmaceutical company, Adynxx, Inc. focuses on bringing to market novel, disease-modifying products for the treatment of pain and inflammation. The Company’s pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including inflammatory and neuropathic pain. Fundamentally, Adynxx is a leader in transcription factor decoy technology. Established in 2007, Adynxx has its corporate headquarters in San Francisco, California.

The Company has worked since its founding to discover and develop transcription factor decoys to modify the course of pain, to collaborate with discovery partners, and to identify in-licensing opportunities with transformative therapeutic profiles to build a pipeline in pain and inflammation.

Adynxx is collaborating with twoXAR to use twoXAR’s artificial intelligence-driven drug discovery platform. This is to identify endometriosis treatments. In addition, Adynxx is evaluating in-licensing opportunities with transformative therapeutic profiles to treat pain and inflammation.

The AYX platform employs a proprietary technology of non-opioid, disease-modifying transcription factor decoys. AYX decoys are short DNA molecules, or oligonucleotides. They selectively inhibit transcription factors controlling the genes involved in the maintenance of pain. Therefore, a single administration of an AYX decoy generates a strong, long-term reduction of pain and associated clinical benefits.

Clinical studies suggest that a single administration of brivoligide at the time of surgery can safely lessen pain for weeks, speed up the time to attain mild pain and considerably decrease the need for opioid use during recovery specifically in patients at greater risk of experiencing increased and prolonged pain following surgery.

Recently, Adynxx announced that Mr. Gregory J. Flesher, Chief Executive Officer (CEO) at Novus Therapeutics, Inc. (NASDAQ: NVUS), was appointed to the Adynxx Board of Directors. Since May of 2017, Mr. Flesher has served as the CEO and a member of the Board of Directors of Novus Therapeutics, a specialty pharmaceutical company centered on developing products for patients with disorders of the ear, nose and throat.

Adynxx, Inc. (ADYX), closed Wednesday's trading session at $0.28, up 55.2106%, on 168 volume with 2 trades. The average volume for the last 3 months is 1,342 and the stock's 52-week low/high is $0.180399999/$2.69000005.

chart

MariMed, Inc. (MRMD)

NetworkNewsWire, CannabisMarketCap, The Cannabis Investor, Pot Stock News, Micro Small Cap, Micro Cap Daily, Insider Financial, Stockhouse, Daily Marijuana Observer, Profit Confidential, Simply Wall St, Proactive Investors, Equity Clock, Stockwatch, Wallet Investor, Trading View, and InvestorsHub reported previously on MariMed, Inc. (MRMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, MariMed, Inc. is one of the largest multi-state cannabis and hemp operators in the U.S. The Company’s dedication is to improving health and wellness with the highest quality hemp and cannabis products. At present, MariMed distributes its branded products in select States. Moreover, the Company is expanding licensing and distribution to many additional markets covering thousands of dispensaries.

MariMed has its corporate office in Norwood, Massachusetts. MariMed announced in late 2018 an investment in Kentucky-based GenCanna, a recognized genetic innovator in industrial hemp.

MariMed offers a complete range of cannabis products and operates state-of-the-art medical and adult-use cannabis dispensaries in six states. In addition, it recently announced the creation of a separate division, MariMed Hemp, centered on the development of industrial hemp-derived CBD products.

The Company is helping build gold standard medical cannabis facilities and programs, one State at a time. It engages in design, development, operation and funding solutions for medical cannabis cultivation centers and dispensaries. The Company’s services include Application Assistance, Real Estate and Safe Access, Build-out and Ongoing Consultation, Business Acceleration Solutions, and Physician and Patient Outreach.

MariMed, across its branded products, including Kalm Fusion™ and Betty’s Eddies™, is at the vanguard of precision dosed branded products for the treatment of specific medical conditions. For dispensaries and cultivation centers already operating, MariMed has a complete set of services to assist in business acceleration, expansion and operational refinement to take the business to the next level.

MariMed has a number of cannabis consulting programs. These include Legal Compliance, Community Outreach, Consensus Building, and Operational Designs. Cannabis consulting programs also include Business Planning and Financial Modeling, Real Estate Selection, Permit Application Preparation, and Systems Design.

Recently, MariMed announced that its MariMed Hemp subsidiary will acquire 70 percent of MediTaurus, LLC. MediTaurus is the owner of the worldwide Florance™ brand of CBD health and wellness products and wide-ranging intellectual property (IP) relating to cannabis formulations.

The Florance™ brand is established in the United States and European Union (EU) with online distributors, wholesalers, pharmacies and physicians. This is the first acquisition for MariMed Hemp, formed to optimize MariMed’s strategic investment in GenCanna Global, Inc., the Kentucky-based producer of compliant, quality CBD derived from hemp.

MariMed, Inc. (MRMD), closed Wednesday's trading session at $0.22, up 30.9524%, on 6,986,548 volume with 1,217 trades. The average volume for the last 3 months is 1,605,657 and the stock's 52-week low/high is $0.100000001/$1.64999997.

chart

Blue Sphere Corp. (BLSP)

DreamTeamNetwork, Hotstocked, Investors Hangout, Biz Journals, Penny Stock General, Stock Shock and Awe, Fast Money Alerts, PennyStocks24, MyBestStockAlerts, OTPicks, PremiereStockAlerts, Dividend Investor, SmallCapVoice, and Infront Analytics reported previously on Blue Sphere Corp. (BLSP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2007, Blue Sphere Corp. is a worldwide Independent Power Producer (IPP). The Company is working to become an important player in the global waste-to-energy and renewable energy markets. It has a business plan that fits the changing regulatory standards for waste and energy. A clean-technology waste-to-energy producer, Blue Sphere is based in Charlotte, North Carolina. The Company has operations in the U.S,  Israel,  and Europe.

Blue Sphere’s main business model is BOO (Build-Own-Operate) - long-term energy agreements are executed with electric companies in advance of projects. Blue Sphere is performing waste-to-energy projects in the U.S. and Italy.  It is pursuing a strategy to work in association with landfill owners to convert harmful methane gas emissions from landfills into electricity. The process is established on readily available technology already being used in different parts of the U.S. and other areas internationally.

Blue Sphere develops, owns, and operates clean-technology, biogas co-generation, as well as waste-to-energy facilities around the world. It chiefly converts organic waste into electricity. In addition, the Company can produce heat, natural gas and organic by-products through an assortment of technologies. 

Blue Sphere has its Charlotte, North Carolina Waste to Energy Anaerobic Digester 5.2 MW Plant. The Output Production is Electricity and Soil Amendment. In Johnston, Rhode Island, Blue Sphere has its Waste to Energy Anaerobic Digester 3.2 MW Plant. The feedstock is organic waste. The Output Production is also Electricity and Soil Amendment.

The Company has acquired 100 percent of the stock of Agricerere, S.R.L., Agrielektra, S.r.L., Agrisorse, S.r.L. and Gefa, S.r.L.  Individually, each totally operational facility generates one megawatt of electricity per hour, which sells to Gestore del Servizi Energetici GSE, S.p.A., a state owned company that promotes and supports renewable energy sources in Italy, under a Power Purchase Agreement  (PPA) that runs through December 31, 2027.

Recently,  Blue Sphere provided an update on its natural oil generator facility in Udine, Italy. At present, the Company is in the process of completing its planned update of the power generation engine at the Undine facility. As part of the facility upgrade, Blue Sphere purchased a Mitsubishi 4-cycle, water-cooled, turbo-charged inline 6. It can generate Nominal Power of 1050 KwH. This engine upgrade will boost the facility's top-end revenue performance by roughly 2 percent.

Blue Sphere Corp. (BLSP), closed Wednesday's trading session at $0.00015, up 50.00%, on 339,954,165 volume with 89 trades. The average volume for the last 3 months is 17,908,081 and the stock's 52-week low/high is $0.000000999/$0.001.

chart

Towerstream Corp. (TWER)

MadPennyStocks, MarketClub Analysis, Money Morning, PennyOmega, OTCBB Journal, OTCMagic, Penny Picks, KingPennyStocks, BUYINS.NET, Damn Good Penny Picks, Penny Stock Prodigy, CoolPennyStocks, Epic Stock Picks, Hit and Run Candle Sticks, HotOTC, Investing Futures, MicroCapDaily, Investment Contrarians, Jason Bond, Broad Street, BullRally, PennyInvest, and ChartPoppers reported on Towerstream Corp. (TWER), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Towerstream Corp. is a leading Fixed-Wireless Fiber Alternative business.  The Company delivers high-speed Internet access to businesses. Together with its subsidiaries, it provides fixed wireless broadband services and delivers access over a wireless network transmitting over regulated and unregulated radio spectrum to commercial customers in the United States. Towerstream has its corporate office in Middletown, Rhode Island.

Towerstream announced earlier in 2018 that its Board of Directors started evaluation of strategic repositioning of the Company as it moves to take advantage of its existing important assets in major American markets. In association with the announcement, Towerstream launched a determined focus on indirect and wholesale channels and the retention of Bank Street Group LLC as its independent financial advisor to explore strategic alternatives with such broadband carriers.

Towerstream provides broadband services in twelve urban markets. These include New York City, Boston, Los Angeles, Chicago, Philadelphia, the San Francisco Bay area, Miami, Seattle, Dallas-Fort Worth, Houston, Las Vegas-Reno, and the greater Providence area.  Towerstream has constructed 175 Major Points of Presence (POPs). The Company positions its POPs on the tops of buildings.

Towerstream is a last-mile facilities-based provider. It owns its entire network. The Company totally bypasses the local exchange carrier and cable providers. Its solution to businesses either complements or replaces existing Internet connections. Towerstream provides property managers, building owners, and their commercial tenants a redundant and reliable dense urban network. This network directly connects to the Company’s fiber backbone. 

Towerstream has its Single Tenant Internet Solution. This solution is for customers not in On-Net buildings. The Single Tenant Internet Solution provides primary and back-up dedicated internet access as a faster and less expensive alternative to fiber. On-Net refers to the extensive number of buildings in Towerstream’s 12 coverage markets now lit for On-Net Business Internet Service. The Company’s On-Net Service provides businesses within its continually growing portfolio of On-Net buildings with dedicated and symmetrical Internet connectivity.

Towerstream Fixed Wireless features fast installation, guaranteed 99.99 percent uptime backed by the Company’s industry leading SLA, and scalability. It also features faster than fiber, true redundancy, and symmetrical speeds.

Towerstream Corp. (TWER), closed Wednesday's trading session at $0.75, up 226.087%, on 417 volume with 6 trades. The average volume for the last 3 months is 725 and the stock's 52-week low/high is $0.200000002/$2.00.

chart

El Capitan Precious Metals, Inc. (ECPN)

HotOTC, StockEgg,  StockRich, TopPennyStockMovers, SmallCapVoice, PennyInvest, CoolPennyStocks,  AllPennyStocks,  PennyTrader Publisher, BullRally, MadPennyStocks, PennyStockVille, and OTCPicks reported on El Capitan Precious Metals, Inc. (ECPN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

El Capitan Precious Metals, Inc. is a mining company based in Scottsdale, Arizona.  It mainly engages in the mining of precious metals and other minerals. The Company chiefly holds interest in the El Capitan gold-silver property situated  close to Capitan, New Mexico, in Lincoln County. El Capitan Precious Metals’ principal asset is its wholly-owned subsidiary El Capitan, Ltd., an Arizona corporation.

The El Capitan, Ltd. subsidiary holds the 100 percent equity interest in the El Capitan property. The Company’s primary objective is the sale of the El Capitan property. 

The El Capitan deposit has been known as a potential iron ore resource for numerous decades. The El Capitan deposit has a near-surface, pervasive nature. All of this takes place above the regional water table. This provides the potential for a low mining cost and a long life operation.

El Capitan Precious Metals owns 3,840 acres of mining property in Lincoln County. This includes 80 acres of patented and 3,760 acres of leased property. These include 188 mining claims. The El Capitan property encompasses 354 Bureau of Land Management (BLM) lode claims and four patented claims.  

El Capitan Precious Metals has enhanced its relationship with Logistica US by way of an agreement under which El Capitan will provide to Logistica concentrated ore to their specifications at the mine site. Logistica will transport, process, as well as refine the precious metals concentrates to sell to precious metals buyers. The agreement is in addition to and complements the previously announced agreement for the sale of iron ore for use in construction. 

In December 2017, El Capitan Precious Metals announced that it entered into an agreement with a refiner that will buy, refine, and sell the hyper-concentrates generated by the pilot plant. Moreover, the Company reported that the refiner has spent a considerable amount of time with its contract miner at the pilot plant and at the mine site.

This past January, El Capitan Precious Metals announced that an agreement was executed in December 2017 for the sale of the Company’s precious metal hyper-concentrates. El Capitan Chairman and Chief Executive Officer, Mr. John F. Stapleton reported that El Capitan reached a final agreement with a buyer and executed a Purchase Agreement for all remaining hyper-concentrates produced by the Pilot Plant from the concentrate materials stored at the bonded warehouse in Tucson, Arizona.

The sale represents the last El Capitan Pilot Program activity. It successfully completes the objectives of the Pilot program. This month, El Capitan Precious Metals reported a breach of contract by the buyer of concentrates. The Company reported that it was informed on March 30, 2018, that the contracted buyer to purchase and process the concentrates from El Capitan Precious Metals decided not to process the material. Instead, the contracted buyer is offering to ship the material back to El Capitan Precious Metals.

El Capitan is investigating the matter. The Company said it will take all necessary and proper steps to pursue civil and criminal litigation of the matter, if appropriate upon further investigation, upon the material being returned. El Capitan Precious Metals will provide further details at the 2018 Shareholder Meeting scheduled for Wednesday, May 23, 2018 in Scottsdale, Arizona.

El Capitan Precious Metals, Inc. (ECPN), closed Wednesday's trading session at $0.016, up 42.3488%, on 680,970 volume with 17 trades. The average volume for the last 3 months is 217,342 and the stock's 52-week low/high is $0.004999999/$0.029999999.

chart

OncBioMune Pharmaceuticals, Inc. (OBMP)

MissionIR, Otcstockexchange, Whisper from Wall Street, and Journal Transcript reported on OncBioMune Pharmaceuticals, Inc. (OBMP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OncBioMune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development of targeted cancer therapies, a proprietary cancer vaccine technology, and commercialization of a portfolio of products globally. OncBioMune has a proprietary Vaccine Technology designed to stimulate the immune system to attack its own cancer while not hurting the patient. The Company incorporates scientifically proven and clinically validated treatments for cancer. OncBioMune Pharmaceuticals is based in Baton Rouge, Louisiana. The Company lists on the OTCQB.

OncBioMune Pharmaceuticals’ lead product is ProscaVax™. This is its novel cancer vaccine for prostate cancer. ProscaVax is now undergoing evaluation in a Phase 1 clinical study at the University of California San Diego Moores Cancer Center and Veterans Hospital in La Jolla, California, funded in part by the Department of Defense US Navy Cancer Vaccine Program.

ProscaVax consists of a combination of prostate cancer associated PSA with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF).

Moreover, the Company has a portfolio of targeted therapies. Some of these are biosimilars to blockbuster drugs. OncBioMune has developed the therapeutic cancer vaccine for prostate cancer patients using similar techniques developed for breast cancer patients.

OncBioMune states that it is tested and laboratory proven and that it could become the standard of care for prostate cancer treatment. OncBioMune Pharmaceuticals uses patented technology developed and or acquired by the Company.

In September 2017, OncBioMune Pharmaceuticals announced that it successfully attained development milestones in formulation and stability with tretinoin, also known as all-trans retinoic acid (ATRA). This is an oral drug for the treatment of Acute Promyelocytic Leukemia (APL). The Company owns the commercialization rights for tretinoin throughout Mexico, Central America, and Latin America.

Recently, OncBioMune Pharmaceuticals provided the latest data from its successfully completed Phase 1 trial of ProscaVax for prostate cancer, suggesting a durable response 31 weeks post-therapy. In the Phase 1 clinical trial, hormone-naïve and hormone-independent recurrent prostate cancer patients with rising prostate specific antigen (PSA) were treated with six intradermal injections of ProscaVax.

Dr. Jonathan Head, Chief Executive Officer at OncBioMune Pharmaceuticals, said, “I’m very excited about this data, as I can’t think of another study to have 75 percent of recurrent prostate cancer patients with rising PSA experience stable disease nearly eight months after therapy ended. .. Now, we have to expand the therapeutic range and increase the number of patients enrolled in mid-stage research, but the data to date certainly is encouraging to provide a safe and effective treatments for the millions of men battling prostate cancer today.”

OncBioMune Pharmaceuticals, Inc. (OBMP), closed Wednesday's trading session at $0.40, up 42.8571%, on 1,072 volume with 8 trades. The average volume for the last 3 months is 4,940 and the stock's 52-week low/high is $0.059999998/$3.00.

chart

The QualityStocks Company Corner

DarioHealth Corp. (NASDAQ: DRIO)

The QualityStocks Daily Newsletter would like to spotlight DarioHealth Corp. (DRIO).

DarioHealth Corp. (NASDAQ: DRIO) was featured today in a publication from BioMedWire, examining how, as the latest innovations are cropping up daily, the health sector is also enjoying those benefits. Several methods of testing and detecting various diseases are being developed day by day. For instance, identifying conditions like cancer at the early stages is growing as the day goes by, and recent discoveries show that any disease can now be detected at its most initial stage. Also today, the company was featured in a publication from BioMedNewsBreaks, which looks closer at how DRIO, a pioneer in the global digital therapeutics market, has released a business update, including financial numbers and corporate achievements for the second quarter ended June 30, 2020. Highlights of the report include the company’s announcement of two Remote Patient Monitoring (“RPM”) agreements in the United States as well as an agreement with Williams Medical, which allowed Dario to enter the United Kingdom. In addition, the company reported Q2 revenues of $1.79 million, a 7.2% sequential increase from Q1 2020. To view the full press release, visit http://ibn.fm/U5RoZ

New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:

  • AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
  • Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.

Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.

Company Strategy

Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).

Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.

Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.

Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.

The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.

The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.

Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.

Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.

Financial Highlights

The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.

Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.

Value to Consumers and Businesses

Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.

Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.

Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.

Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.

Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.

Recent Studies

The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.

Remote Patient Monitoring (RPM) Agreements

The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.

This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.

Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters

In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.

As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.

Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.

Awards and Recognition

DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”

‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.

DarioHealth Corp. (DRIO), closed Wednesday's trading session at $14.7, up 8.1678%, on 677,537 volume with 3,805 trades. The average volume for the last 3 months is 220,781 and the stock's 52-week low/high is $3.01999998/$18.834999.

Recent News

chart

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER)

The QualityStocks Daily Newsletter would like to spotlight The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER).

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused waters and CBD-infused products, today announced that its entire line of beverage offerings, including flavored waters, will be carried by Mahaska, a leading direct-store-deliver (“DSD”) provider in some of the major markets in the Midwest. To view the full press release, visit http://cnw.fm/ynnpc. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Cannabis legalization activists in Arizona can finally breathe easy after a judge dismissed a lawsuit claiming that their recreational cannabis legalization measure was unfit for the November ballot. Last month, Arizonans for Health and Public Safety filed a lawsuit arguing that the measure wasn’t accurately described in the 100-word summary included in the petitions that voters signed. The group said that plenty of information was left out of the summary, denying voters all the information they needed to make an informed decision.

Founded in 2012, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes, along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked label ‘Clean Beverage’. Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 Infusedâ„¢ in 2019 to meet consumer demand for flavor-infused products. A88 Infusedâ„¢ flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched the A88CBDâ„¢ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies and powder packs.

Innovation and Expansion

Founded in 2012, The Alkaline Water Company began with a mission to create the best-tasting water in the world. At the time, there were two emerging trends in health-conscious consumers: a growing interest in the alkaline diet and perceived health benefits of pink Himalayan rock salt. By combining these two concepts in an alkaline water and trademarking the name Alkaline88, The Alkaline Water Company began offering what it calls the smoothest tasting Clean Beverageâ„¢ in the U.S. enhanced-water category.

Now a top bulk alkaline-water brand (the company reported record sales in March and April 2020, surpassing March and April 2019 numbers by 114% and 171%, respectively), The Alkaline Water Company is committed to growing its national footprint through innovation and expansion. That mindset was evident as the company introduced eco-friendly aluminum bottles and branched out into flavor-infused waters; the company currently offers six different flavors: peach/mango, lemon/lime, raspberry, watermelon, blood orange and lemon.

The company’s commitment to innovation may be most evident in its newest product line: A88CBD. This line of CBD-infused products includes tinctures, capsules, gummies, salves, balms, hand and foot lotions, essential oils, bath bombs and bath salts, as well as CBD-infused drinks, water and beverage shots. These quality, CBD-infused offerings are all made with lab-tested, full-spectrum hemp and are conveniently packaged and perfect for on-the-go or at home use.

In addition, The Alkaline Water Company has implemented an aggressive growth strategy, with numerous organic initiatives focused on national multichannel, mass-market expansion through a direct-to-warehouse model and co-packing facilities that are strategically located within 600 miles of 95% of the U.S. population. In addition to this strong brick-and-mortar approach, the company recently launched a B2C e-commerce platform (www.A88CBD.com) and aggressive digital-marketing campaigns.

Clear Advantages in a Growing Market

With consistent growth year over year, the company reported $32.2 million in revenue in fiscal 2019 and has emerged as a growth leader in the functional (value-added) waters space, which is the fastest-growing segment of the bottled water industry.

The Alkaline Water Company’s efforts are focused on its clear competitive advantages, including its strong marketing (the inclusion of alkaline in product names); existing grocery channels, which feature excellent relationships and a nationwide broker network; distinctive branding; proprietary technology, which produces great-tasting, high-quality water, infused drinks and other products; and price, with a broad range of products in all formats, from bulk bottles to single serve.

As the company focuses on strategic growth, it is eyeing the impressive potential of a market that is on a strong upswing. Annual bottled water sales have now surpassed soda consumption, with soda sales in the United States having declined by $1.2 billion over the past five years. Some research indicates that the global bottled water market will reach an estimated $280 billion this year, while the CBD market is forecast to top $20 billion by 2024.

With its products available in all major trade channels, including grocery stores, drug stores, c-stores and big-box retailers, The Alkaline Water Company is also looking to expand into new spaces, such as health and beauty, hospitality and specialty retailer locations.

Seasoned Management Team

The Alkaline Water Company is led by an experienced team focused on the company’s core strategy of building a national retail footprint and extending its lifestyle brands into other consumer packaged goods categories.

Richard A. Wright, President, CEO and Co-Founder of The Alkaline Water Company Inc., oversees all aspects of the business, successfully guiding the company through strategic opportunities and delivering greater than 50% growth since the company’s inception. A passionate and versatile leader with a strong track record of innovation, collaboration and achieving goal-driven results, Wright is a serial entrepreneur with more than 41 years of experience. Early in his career, he spent years at one of the ‘Big Four’ accounting firms, working his way up to Regional Director of Tax and Financial Planning. As a CPA, entrepreneur and former CFO, Wright brings extensive knowledge of finance, operations, sales and marketing to the team, and he has participated in hundreds of M&A transactions throughout his career.

David Guarino, CFO, Secretary, Treasurer and Director, earned a Bachelor of Science in accounting and a Master of Accountancy from the University of Denver. From 2008 to 2013, Guarino was President and a Director of Kahala Corp., a worldwide franchisor of multiple quick-service restaurant brands with locations in 49 states and more than 25 countries. From 2014 to 2015, Guarino was President of HTI International Holdings Inc., a technology company focused on forward osmosis water filtration technology.

Frank Chessman, National Sales Manager, is a graduate of the University of Southern California’s Marshall School of Business. He spent 25 years with Ralph’s Grocery, Kroger’s largest division, working at many levels before ultimately becoming Vice President of Advertising & Marketing. He then served 14 years as Executive Vice President at Simon Marketing. Chessman has more than a decade of experience in the beverage manufacturing industry.

Brian Sudano, Director, is managing partner of Beverage Marketing Corporation and BMC Strategic Associates. Sudano’s experience covers nearly the entire beverage industry, from energy drinks to wine, with special expertise in beverage alcohol by virtue of varied industry experience across a broad range of projects. Sudano manages several major clients, providing ongoing strategic and market advice and leading projects in strategic planning, market entry analysis and planning, sales/distribution, business modeling, brand repositioning and international opportunity assessment. He has spoken at many beverage industry events and is a contributing editor at Beverage World magazine.

Aaron Keay, Chairman, has been a successful investor, entrepreneur and financier to multiple small cap and startup companies over the last decade. During his time with these companies, he served in advisor, board-member and senior-management roles. His experience ranges across multiple sectors in mining, biotech, health and wellness, tech and cannabis, where he has invested and raised more than $500 million.

The Alkaline Water Company Inc. (NASDAQ: WTER), closed Wednesday's trading session at $1.79, up 9.816%, on 1,055,087 volume with 2,734 trades. The average volume for the last 3 months is 1,555,762 and the stock's 52-week low/high is $0.400000005/$2.79999995.

Recent News

chart

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

The largest uranium mining company in the United States, Energy Fuels (NYSE American: UUUU) (TSX: EFR) has eliminated one-half of its debt, plans to be debt free by the end of the year, and anticipates having $30 million of inventory value by the close of 2020 (http://ibn.fm/YpNEV). The company holds three of America’s key uranium production centers, including the White Mesa Mill, the only conventional uranium mill currently operating in the United States today.

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon-free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

 

Energy Fuels Inc. (UUUU), closed Wednesday's trading session at $1.71, up 1.7857%, on 1,665,752 volume with 3,416 trades. The average volume for the last 3 months is 1,498,290 and the stock's 52-week low/high is $0.779999971/$2.3499999.

Recent News

chart

Kingman Minerals Ltd. (TSXV: KGS)

The QualityStocks Daily Newsletter would like to spotlight Kingman Minerals Ltd. (TSXV: KGS).

Kingman Minerals (TSX.V: KGS), a Canada-listed gold miner with extensive claims in key mining jurisdictions spanning North America, is readying a drill campaign focused on confirming the viable ore deposits within its Mohave Project (http://nnw.fm/tp09q). The project, located within the Music Mountains in Mohave County, Arizona, is comprised of 20 lode claims that include the historic Rosebud Mine. To view the full article, visit: http://nnw.fm/8nTYw.

Kingman Minerals Ltd. (TSXV: KGS), formerly Astorius Resources Ltd., is engaged in the acquisition, exploration and development of gold and silver properties in North America. The Canada-based company is focused on sourcing and developing high-quality properties in favorable mining locations to advance its diverse portfolio of low-cost, lifelong assets.

Kingman Mine

The Company maintains the following projects:

The Mohave Project: Located in the Music Mountains in Mohave County, Arizona. Approximately 35 miles from the town of Kingman, the property consists of 20 lode claims, including the historic Rosebud Mine. The Company has entered into an option agreement to earn 100% over four years. According to historic mappings of the mine, probable ore is 15,560 tons. Possible (inferred) ore is comprised of 176,000 tons, and additional possible (inferred) ore totals slightly over 1,100,000 tons. The total contained gold ounces for all categories is estimated at 664,000 ounces, and contained silver is estimated at 2,600,000 ounces. The Company has recently completed two underground reconnaissance and sampling programs and is in the process of verifying previous resource estimates.

 

The Cadillac East Property: Located approximately 55 kilometers east of Val d’Or, a hub for exploration and mining activities in the Canadian province of Quebec. The Company acquired a 100% interest in the property from an arm’s length vendor. Cadillac East Property consists of 12 claims, and the Company has an option agreement to earn 100% over three years. Having been the subject of numerous geophysical and geological surveys, the Cadillac East Property has been explored and surveyed by numerous companies as well as by the Quebec government. Exploration work done in 2017 by Exploration Facilitation Unlimited Inc. revealed multiple potential targets for future investigation, as results from the soil program identified value in gold, silver, copper, zinc and nickel.

Kingman Minerals is focused on enhancing shareholder value as it continues exploring potential assets and acquiring strategic gold targets. The company recently commissioned mining consulting services company Burgex Mining Consultants Inc. to complete two underground gold exploration programs in the historic Rosebud Mine. Burgex specializes in mineral exploration, mining claim staking, landman services, mining consulting, and the access and documentation of abandoned mine sites throughout the western United States and the world. Burgex’s founders have been active in the industry since 2007 and have identified, secured and consulted on hundreds of thousands of acres of mineral properties spanning a wide range of mineral commodities with billions of dollars’ worth of resources and reserves. The Burgex team has been featured in Forbes Magazine as well as on the Discovery Channel and other outlets. Burgex is at the vanguard of industry advancements in safely accessing difficult vertical abandoned mine workings and continues to pioneer new mineral exploration methods with strategic partners throughout the United States and the world.

Gold’s Predicted Rise

The value of gold is currently on an upward climb due to COVID-19’s upending of the global economy, causing governments to expand their balance sheets. In 2019, as a result of the housing and financial crisis, gold saw its best performance since 2010 — increasing as much as 20% and hitting a top price of $1,549 per ounce in September of that year. Analysts predict its price will continue to climb due to strong buying by central banks, a weakening of the U.S. dollar, and increasing political tensions. A recent Wolfe Research report predicted gold would hit an all-time high, referencing an ounce of gold that commanded a $1,515 asking price. As the value of the U.S. dollar weakens, the demand for gold is inversely rising. Known as a safe-haven asset, gold tends to see increased levels of demand during times of consumer fear or recession.

Management

Sandy MacDougall – Chairman and Director
An economics graduate from the University of British Columbia, Sandy MacDougall brings 30+ years of experience in the investment banking and finance industry to KGS. He was instrumental in the acquisition, development and production of gold at the Alto el Toro mine near Ibaguel, Columbia. As a former investment advisor at Canaccord Capital Corp., MacDougall was a key player in multiple significant financings in Canada as well as abroad, working with a wide range of companies. His experience has afforded him critical exposure to precious and base metal projects throughout North and South America, and he has served as chairman of the board since 2016.

Arthur Brown – President and Director
With 36 years of business experience and service to the boards of eight other companies in sectors ranging from technology to oil, gas and mineral exploration, Arthur Brown adds substantial knowledge in corporate structure and development as well as financings and venture capital to the KGS team.

Cyrus Driver – Independent Director
Cyrus Driver was a founding partner in the firm of Driver Anderson from its inception in 1982 and is a chartered accountant as well as a retired partner in the firm of Davidson and Company LLP. Aside from providing general public accounting services to a diverse range of clients, his specialty is servicing TSX Venture-listed companies and members of the brokerage community. With expert knowledge of the securities industry and its regulations, Driver lends valuable advice to his clients regarding finance, taxation and other accounting-related matters. He currently serves as director and chief financial officer of several TSX-V-listed companies.

Dr. Peter Born – Director and Technical Specialist
A professional geologist registered with the Association of Professional Geoscientists of Ontario and a fellow of the Geological Association of Canada, Dr. Peter Born brings 30+ years of experience in exploration and mining to the company. With prior roles as a senior geologist with Western Mining Corporation, he is currently working with RPS Energy Canada Ltd. on natural gas plays related to high-temperature dolomites and sedimentary zinc deposits (MVT) within the Appalachian Basin in the United States. Dr. Born holds a Ph.D. in earth sciences and has expertise in Precambrian sedimentary geology, basin analysis, sedimentology, stratigraphy and sedimentary ore deposits.

Kingman Minerals Ltd. (TSXV: KGS), closed Wednesday's trading session at $0.09, up 5.88%, on 40,000 volume with 3 trades. The average volume for the last 3 months is 114,553 and the stock's 52-week low/high is $0.07/$0.22.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Mullen Technologies (“Mullen”) plans to bring electric vehicle (“EV”) manufacturing to West Plains, Washington through a proposed merger with Net Element (NASDAQ: NETE), a global technology group based in Miami that operates electronic payment services. While still in its planning stages, the new EV manufacturing facility will comprise 1.3 million square feet of assembly and manufacturing space. A total of nearly 4000 jobs are expected to be created that include 55 at startup, 863 by 2026, and an additional 3,000 from the research and development of lithium-ion batteries through Mullen’s subsidiary company, Mullen Energy. Also today, NetworkNewsWire released a report on the company detailing how, since 2013, the sale of electric vehicles (EV) in the United States has grown by an average of 25% a year (http://nnw.fm/B2GRb ), a stunning figure when compared to the anemic 1.4% overall growth of the US auto market over the same interim (http://nnw.fm/hwjS2 ). Despite the stellar growth rate, EV sales only account for a miniscule 2% share of the US automobile market but are projected to exceed 20% of annual vehicle sales by 2030 . With a tenfold increase in market share expected over the next decade, market penetration has just begun, and there’s clearly still enormous upside. 

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.

Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Wednesday's trading session at $9.39, off by 8.2111%, on 543,716 volume with 3,453 trades. The average volume for the last 3 months is 1,693,535 and the stock's 52-week low/high is $1.472/$20.0783996.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of a key U.S. patent entitled "Sample Preparation Devices and Methods." According to the update, the new patent (U.S. 10,710,082) brings the company's intellectual property ("IP") estate up to a total of 25 issued patents. To view the full press release, visit http://nnw.fm/jNfnD

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Wednesday's trading session at $2.00, off by 4.7619%, on 6,007 volume with 28 trades. The average volume for the last 3 months is 18,946 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

chart

Sustainable Green Team Ltd. (SGTM)

The QualityStocks Daily Newsletter would like to spotlight Sustainable Green Team Ltd. (SGTM).

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally-beneficial solutions for tree and storm waste disposal, recently added new grapple hauling trucks to its fleet as part of the company’s strategy focused on expanding its vertically integrated operations. Through its subsidiaries, SGTM transforms natural waste created by hurricanes, ice storms and floods into useful organic products that benefit the environment through tree services that include debris hauling, biomass recycling, waste removal, mulch manufacturing, packaging and sales, and the production of playground surface material.

Sustainable Green Team Ltd. (OTC: SGTM), through its subsidiaries, including National Storm Recovery LLC (DBA Central Florida Arbor Care and Mulch Manufacturing Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

SGTM and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

SGTM’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

SGTM in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides SGTM with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

SGTM’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

SGTM plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as its flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow SGTM’s debris hauling division to realize significant savings on its transportation costs.

SGTM has chosen as its new headquarters the 100,000-square-foot Mulch Manufacturing building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing Inc. and National Storm Recovery LLC and has ample room to expand as needed.

Leadership

SGTM’s leadership team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

Sustainable Green Team Ltd. (OTC: SGTM), closed Wednesday's trading session at $1.50, off by 14.2857%, on 2,650 volume with 12 trades. The stock's 52-week low/high is $0.05/$2.19000005.

Recent News

chart

The Movie Studio Inc. (OTC: MVES)

The QualityStocks Daily Newsletter would like to spotlight The Movie Studio Inc. (OTC: MVES).

The Movie Studios (OTC: MVES), an independent motion picture production company located in Florida, leverages a strategic business model based on the purchase of legacy film libraries that have been upgraded to 4K resolution along with the re-monetization of new content on popular video on demand (“VOD”) streaming platforms. To view the full article, visit: http://nnw.fm/mEcNT

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The company has launched The Movie Studio App on Google Play and the App Store, enabling users to both view the company’s content and potentially become part of it. The app is in the completion stage, and The Movie Studio is conducting its final beta test of the app’s unique “audition submission” function, leveraging the company’s “Watch Our Movies, Be in Our Movies!” content platform and “Everyone’s a Star” campaign, which will be marketed via social media. Using the app, subscribers can upload a thumbnail photo of themselves along with a selfie video audition submission that showcases them reading character dialog. Audition submissions will then be reviewed by producers for possible participation of the auditionee in upcoming feature films.

The audition submission function provides the subscriber the ability to disrupt traditional motion picture casting and management, enabling access to participation in The Movie Studio’s independent motion picture and media content. At the same time, for the company this significantly reduces capital expenditures associated with those traditional media mechanisms. The Movie Studio’s unique business model capitalizes on the global demand for film content through the production and distribution of its own films while also providing opportunities for direct viewer involvement in its content.

The company operates using a growth-by-acquisition strategy that includes:

  • Purchasing legacy film libraries.
  • Upgrading acquired films to 4K resolution and remonetizing with “new” film content on popular VOD streaming platforms across the internet.
  • Strategic partnerships and media content alignment with other OTT platforms and cross-collateralization of leverageable media assets for worldwide distribution.
  • Producing micro-budget motion picture content with substantial production value utilizing new 4K technology and the company’s extensive legacy resources and unique production process, thereby significantly reducing capital expenditures while allowing for the potential of significant return on investment (ROI) with one successful production.
  • Controlling its revenue streams through server-driven geo-fracturing global territories and its own OTT platform.

Currently, The Movie Studio is producing three upcoming feature films: “Cause and Effect,” “The Last Warhead” and “PEGASUS” — all with completed electronic press kits and pitch decks and fully produced motion picture-quality trailers ready for talent, distribution and financial integration.

The company has been successful in producing, casting and distributing its films on major SVOD platforms without recognizable stars, which reduces capital expenditures. However, The Movie Studio intends to integrate recognizable stars into the productions at value propositions either pre- or post-completion of the intellectual property.

Through successful beta testing, The Movie Studio has monetized film assets on the Amazon, tubi tv, Comcast and Showtime platforms.

The company’s proposed server-based model will provide licensing payment from global territories without third-party distribution fees, which have traditionally been as high as 35%.

Founded in 1961 and formerly known as Destination Television, Inc., the company changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio is headquartered in Fort Lauderdale, Florida.

Cord-Cutting Creates Opportunity for VOD Players

Consumers are no longer content waiting for their favorite programming to come on the air – they expect instant streaming access where and how they want it. This has led to increased “cord cutting,” with consumers severing ties with their traditional pay TV providers in favor of digital streaming services.

With the advent of smart TVs with app integration, consumers can now watch what they want to watch when they want to watch it, fracturing traditional cable bundling mechanisms.

With pay TV usage steadily declining – satellite and cable TV businesses in the United States lost approximately 6 million customers in 2019 alone – streaming platforms are poised to potentially replace traditional pay TV distribution models altogether. Approximately 12,000 U.S. consumers are cutting the cord every day.

As this shift in media delivery continues and as digital devices become more sophisticated and bandwidth increases, VOD platforms have the potential to scale significantly. The Hollywood “streaming wars” of recent years have created an environment in which smaller competitors, like The Movie Studio, are able to emerge as major brands.

The Movie Studio Inc. (OTC: MVES), closed Wednesday's trading session at $0.00865, off by 3.8889%, on 174,306 volume with 10 trades. The average volume for the last 3 months is 192,960 and the stock's 52-week low/high is $0.006099999/$0.056099999.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTCQB: SGMD) was featured today in the 420 with CNW by CannabisNewsWire. Although the 2014 hemp pilot program is set to expire on October 31, various state agriculture and hemp industry advocates have expressed concern that some states aren’t quite ready to run their own hemp programs. On Wednesday, the U.S. Department of Agriculture (“USDA”), received letters from the National Association of State Departments of Agriculture (“NASDA”) and National Industrial Hemp Council (“NIHC”) asking it to extend the pilot hemp program.

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Wednesday's trading session at $0.0024, off by 7.6923%, on 41,988,420 volume with 407 trades. The average volume for the last 3 months is 67,382,825 and the stock's 52-week low/high is $0.001599999/$0.021999999.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ: GNPX) was featured today in a publication from BioMedWire, examining how people with type two diabetes are more likely to suffer broken bones than non-diabetic persons. As the number of people with diabetes rises, the skeletal brittleness in persons with type two diabetes is also increasing, and much is not known about the reasons responsible for this reality. The bone’s fragility is usually attributed to its density, but that is not the case with type two diabetes patients since they have normal bones. The puzzle is that they still suffer from fractures at a very high rate. However, researchers are on the verge of establishing the cause of these high fragilities in bones.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprexâ„¢ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprexâ„¢, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprexâ„¢ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprexâ„¢.

Genprex Inc. (NASDAQ: GNPX), closed Wednesday's trading session at $3.65, up 1.9553%, on 548,640 volume with 2,161 trades. The average volume for the last 3 months is 1,722,890 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TSX: TGOD) (US: TGODF), a leading producer of premium certified organic cannabis, announced today its financial results for the second quarter of 2020 ended June 30, 2020.  These filings are available for review on the Company's SEDAR profile at www.sedar.com.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Wednesday's trading session at $0.33435, up 2.8769%, on 919,975 volume with 396 trades. The average volume for the last 3 months is 1,274,132 and the stock's 52-week low/high is $0.150000005/$2.65000009.

Recent News

chart

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (OTCQB: NUGS).

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, has released monthly performance data for July. Those numbers — $2.3 million in total sales from cannabis products — exceeded company projections and mark a record sales performance for the company. The report attributes much of this record-breaking growth to its improved positioning in the California cannabis market among partners and distributors. To view the full press release, visit http://cnw.fm/oaEga. Also today, the company was highlighted in a publication from FinancialNewsMedia.com, examining how the North American cannabis market, which has been steadily growing over the past few years, is projected to continue and even accelerate in the years to come. Retail sales of medical and recreational cannabis in the United States are on pace to eclipse $15 billion by the end of 2020, an increase of approximately 40% over 2019 sales figures, according to exclusive projections from the 2020 edition of the Marijuana Business Facebook as quoted in the Marijuana Business Daily. Total U.S. sales could rise as high as $37 billion by 2024, according to projections. The coronavirus pandemic, however, has thrown a huge curveball at projections. 

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHireâ„¢ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHireâ„¢ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganixâ„¢,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), closed Wednesday's trading session at $0.082, up 13.1034%, on 3,776,806 volume with 367 trades. The average volume for the last 3 months is 1,653,225 and the stock's 52-week low/high is $0.025499999/$0.499900013.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF).

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF) has released its financial and operating results for the three and six months ended June 30, 2020, reporting significant advancement in its operations and strong liquidity. Willow ended the quarter in a strong financial position, with approximately $12.2 million in cash on hand. During the second quarter of 2020, Willow, along with its development partner, Albany Molecular Research, Inc. ("AMRI"), focused on three key development components: increasing cannabinoid product concentrations, optimizing the fermentation process, and developing a cost-effective downstream isolation and purification process. Through execution of this strategy, Willow has now achieved ample performance to initiate a 500 litre pilot-scale campaign to advance its scaling development toward commercial production and generate product samples for multiple interested consumer packaged goods companies.  

Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQX: CANSF), closed Wednesday's trading session at $0.538, off by 0.102126%, on 14,479 volume with 12 trades. The average volume for the last 3 months is 50,964 and the stock's 52-week low/high is $0.218999996/$0.738600015.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday's trading session at $3.07, up 5.8621%, on 55,777 volume with 220 trades. The average volume for the last 3 months is 78,467 and the stock's 52-week low/high is $1.04999995/$3.74.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.